| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/06/2002 | WO2002044228A2 Liquid dispersion polymer compositions, their preparation and their use |
| 06/06/2002 | WO2002043806A2 In vivo delivery methods and compositions |
| 06/06/2002 | WO2002043785A2 Intraocular implants for preventing transplant rejection in the eye |
| 06/06/2002 | WO2002043774A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 06/06/2002 | WO2002043773A2 Tissue specific prodrugs |
| 06/06/2002 | WO2002043772A2 Water-soluble polymer conjugates of triazine derivatives |
| 06/06/2002 | WO2002043771A2 Conjugates of glycosylated/galactosylated peptide |
| 06/06/2002 | WO2002043770A2 Homing peptide multimers, their preparation and uses |
| 06/06/2002 | WO2002043769A2 Neutral and anionic colloidal particles for gene delivery |
| 06/06/2002 | WO2002043768A1 Molecular inclusion compounds consisting of biocatalytically obtained, linear, water-insoluble polysaccharides and of fatty acids or their derivatives |
| 06/06/2002 | WO2002043767A1 Improved oral delivery of peptides using enzyme-cleavable membrane translocators |
| 06/06/2002 | WO2002043765A2 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
| 06/06/2002 | WO2002043756A2 Method for obtaining antigenic aggregates and the use thereof in formulations |
| 06/06/2002 | WO2002043750A2 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations |
| 06/06/2002 | WO2002043739A2 Dermatological formulations containing clindamycin and a zinc-salt |
| 06/06/2002 | WO2002043729A1 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid |
| 06/06/2002 | WO2002043723A1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt |
| 06/06/2002 | WO2002043721A1 Treatment of statin side effects |
| 06/06/2002 | WO2002043708A2 Magnetic particles for the targeted regional therapy |
| 06/06/2002 | WO2002043699A2 Preparation of large liposomes by infusion into peg |
| 06/06/2002 | WO2002043696A1 Solvent systems for pharmaceutical agents |
| 06/06/2002 | WO2002043695A2 Stable, aerosolizable suspensions of proteins (e.g. insulin, dnase) in ethanol |
| 06/06/2002 | WO2002043694A2 Edible pga(propylene glycol alginate) coating composition |
| 06/06/2002 | WO2002043692A1 Method for making a cell activating implantable composition |
| 06/06/2002 | WO2002043691A1 Skin cream stimulating the surface bloodstream |
| 06/06/2002 | WO2002043686A2 Acid cosmetic, dermatological and pharmaceutical agents |
| 06/06/2002 | WO2002043672A1 Fine-grained emulsions |
| 06/06/2002 | WO2002043665A2 Ahf associated dispersion system and method for preparation |
| 06/06/2002 | WO2002043663A2 Tetrapartate prodrugs |
| 06/06/2002 | WO2002043661A2 Recombinant anti-cd30 antibodies and uses thereof |
| 06/06/2002 | WO2002043646A1 Methods and apparatus for making seamless capsules |
| 06/06/2002 | WO2002043611A1 Dispensing device |
| 06/06/2002 | WO2002043567A2 A method of treating cancer |
| 06/06/2002 | WO2002028895A3 Cyclic peptides, method for preparing same and use as angiogenesis inhibitor or activator |
| 06/06/2002 | WO2002028426A8 Split enveloped virus preparation |
| 06/06/2002 | WO2002026372A3 Instant water dissolvable encapsulate and process |
| 06/06/2002 | WO2002024001A3 Animal feed supplement containing d-pantothenic acid and/or its salts, improved method for the production thereof, and its use |
| 06/06/2002 | WO2002022172A3 Powdered/microfibrillated cellulose |
| 06/06/2002 | WO2002015844A3 Antimicrobial composition and methods of use in the treatment of disease |
| 06/06/2002 | WO2002014448A3 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 06/06/2002 | WO2002007704A3 Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone |
| 06/06/2002 | WO2002007683B1 Antimicotic nail varnish composition |
| 06/06/2002 | WO2002003914A3 Improved thyroid hormone formulations |
| 06/06/2002 | WO2002000261A3 Surfactant-containing formulations for extended release of somatotropin |
| 06/06/2002 | WO2001090129A3 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds |
| 06/06/2002 | WO2001089576A3 Preparation hypericin bonded with poly-n-vinylamides |
| 06/06/2002 | WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods |
| 06/06/2002 | WO2001085681A3 3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same |
| 06/06/2002 | WO2001080840A3 Cytotoxic agents comprising single-stranded and/or looped dna |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001072323A3 Use of insulin for the treatment of cartilagenous disorders |
| 06/06/2002 | WO2001049324A3 Novel colloid synthetic vectors for gene therapy |
| 06/06/2002 | WO2001045727A3 Stabilized veterinary compositions comprising more than one antiviral agent |
| 06/06/2002 | WO2001036003A8 Selective cellular targeting: multifunctional delivery vehicles |
| 06/06/2002 | WO2001012232A8 Process to make a sustained release formulation |
| 06/06/2002 | WO1999002120A8 Compositions and methods for reversibly increasing permeability of biomembranes |
| 06/06/2002 | US20020068818 Conjugation of biomolecules using diels-alder cycloaddition |
| 06/06/2002 | US20020068750 Mitochondria protecting agents for treating mitochondria associated diseases |
| 06/06/2002 | US20020068720 Containing s cyclodextrin compound in a concentration sufficient to maintain the drug in solution at such a drug concentration. |
| 06/06/2002 | US20020068717 Methods and compositions for enhancing diffusion of therapeutic agents through tissue |
| 06/06/2002 | US20020068699 Clostridial toxin derivatives and methods for treating pain |
| 06/06/2002 | US20020068693 Non-aqueous surfactant-containing formulations for extended release of somatotropin |
| 06/06/2002 | US20020068356 Method of removing gas from a site using gas vesicles of cells |
| 06/06/2002 | US20020068328 Liposomal pharmaceutical conjugate for use inthe treatment and diagnosis of tumors; antitumor agents; anticarcinogeneic agents |
| 06/06/2002 | US20020068327 Non-naturally occurring targeted lipolytic compounds and related compositions and methods |
| 06/06/2002 | US20020068187 Comprising growing magnetic core material and coating surface with diamagnetic coating; use as inductor materials, magnetoresistance sensors, directed drug delivery agents |
| 06/06/2002 | US20020068121 Blends of isoflavones and flavones |
| 06/06/2002 | US20020068113 A calcium double salt of organic (preservative) acids of formula Ca(R1)(R2) where R1 and R2 are different and are each OOC-R3, R3=saturated or monounsaturated or polyunsaturated c1-c5-alkyl, C1-C5-hydroxyalkyl or phenyl |
| 06/06/2002 | US20020068098 Combinations of diterpene triepoxide lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2 |
| 06/06/2002 | US20020068096 Antimonocytic activity of betel leaf extracts |
| 06/06/2002 | US20020068092 Stabilizers prevent aggregation of nanoparticles and increase bioadhesion to substrates such as an insect, teeth, bone, nails, chitin, feathers, scales, mucous, skin, hair, and/or plant tissue |
| 06/06/2002 | US20020068091 Comprises biodegradable and biocompatible polymer carrying cationic charge on suface; sustained release/drug delivery |
| 06/06/2002 | US20020068089 Comprises biocompatible hydrophilic cationic microparticles and cell adhesion promoter implanted into the lower esophageal sphincter |
| 06/06/2002 | US20020068087 Bioadhesive hydrogels with functionalized degradable crosslinks |
| 06/06/2002 | US20020068083 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 06/06/2002 | US20020068077 Methods and compositions for reducing side effects in chemotherapeutic treatments |
| 06/06/2002 | US20020068071 Enhancement of the cellular immune response |
| 06/06/2002 | US20020068065 Pharmaceutical composition having specific water activity |
| 06/06/2002 | US20020068056 Monoclonal antibodies (mabs) against tumor-associated antigens, the preparation and use thereof |
| 06/06/2002 | US20020066978 Method of forming articles including waveguides via capillary micromolding and microtransfer molding |
| 06/06/2002 | US20020066687 Container |
| 06/06/2002 | DE10060470A1 Thermoplastische und wasserlösliche Celluloseether-ester Thermoplastic and water-soluble cellulose ether-ester |
| 06/06/2002 | DE10060140A1 Multimerer mehrfach-antigenbindender einzelkettiger Antikörper Multimeric multiple antigen-binding single chain antibody |
| 06/06/2002 | DE10059430A1 Feinteilige Emulsionen Fine-particle emulsions |
| 06/06/2002 | DE10058384A1 Kosmetisches oder dermatologisches Mittel in Form eines cremigen Permanentschaums oder einer stabil aufgeschäumten Creme Cosmetic or dermatological agent in the form of a creamy permanent foam or stable foamed cream |
| 06/06/2002 | CA2449412A1 Receptor-mediated uptake of peptides that bind the human transferrin receptor |
| 06/06/2002 | CA2436882A1 Dispensing device |
| 06/06/2002 | CA2436348A1 Preparation of large liposomes by infusion into peg |
| 06/06/2002 | CA2431839A1 Conjugates of glycosylated/galactosylated peptide |
| 06/06/2002 | CA2430559A1 Method of making a protein polymer and uses of the polymer |
| 06/06/2002 | CA2430239A1 A method of treating cancer |
| 06/06/2002 | CA2430139A1 Stable, aerosolizable suspensions of proteins in ethanol |
| 06/06/2002 | CA2430137A1 Method for the stabilizing of biomolecules (e.g. insulin) in liquid formulations |
| 06/06/2002 | CA2430087A1 Photochemical internalization for delivery of molecules into the cytosol |
| 06/06/2002 | CA2430077A1 Modified arginine deiminase |
| 06/06/2002 | CA2429803A1 Neutral and anionic colloidal particles for gene delivery |
| 06/06/2002 | CA2429464A1 Liquid dispersion polymer compositions, their preparation and their use |
| 06/06/2002 | CA2428018A1 Tetrapartate prodrugs |
| 06/05/2002 | EP1211319A2 Gene transfer into pancreatic and biliary epithelial cells |
| 06/05/2002 | EP1211258A1 Process for preparing solubilizing adjuvants from fusel oils and oses |